NRC — NRC Health stock price, charts and financials

QT64NRC Health

NRC Health (NASDAQ: NRC) is a Healthcare company in the Medical - Healthcare Information Services industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
20.78
+0.44+2.16%
NRCQT64NRC Health·NASDAQ
20.78+2.16%
TA
Loading chart...
Screen all →
Snapshot
Index-P/E77.49EPS (ttm)0.26Insider Own-Shs Outstand22.54MPerf Week4.25%
Market Cap458.40MForward P/E18.32EPS next Y1.11Insider Trans0.03%Shs Float11.84MPerf Month-6.31%
Enterprise Value545.10MPEG-EPS next Q0.21Inst Own-Short Float4.40%Perf Quarter8.60%
Income6.00MP/S3.27EPS this Y252.00%Inst Trans-Short Ratio4.25Perf Half Y27.68%
Sales139.99MP/B68.36EPS next Y26.14%ROA4.30%Short Interest520.82KPerf YTD8.36%
Book/sh-P/C15.17EPS next 5Y14.81%ROE48.46%52W High24.19 -14.10%Perf Year43.64%
Cash/sh-P/FCF21.18EPS past 3/5Y-25.74% -18.54%ROIC8.75%52W Low11.25 84.74%Perf 3Y-53.60%
Dividend Est.0.64 (3.08%)EV/EBITDA23.30Sales past 3/5Y-3.40% 0.59%Gross Margin66.79%Volatility4.00% 5.71%Perf 5Y-61.46%
Dividend TTM0.60 (2.89%)EV/Sales3.89EPS Y/Y TTM-75.96%Oper. Margin10.53%ATR (14)1.20Perf 10Y28.49%
Dividend Ex-DateSep 25, 2026Quick Ratio0.65Sales Y/Y TTM-2.10%Profit Margin4.18%RSI (14)49.40Recom2.00
Dividend Gr. 3/5Y-14.77% 19.88%Current Ratio0.65EPS Q/Q10.71%SMA20-1.81%Beta0.37Target Price-
Payout216.92%Debt/Eq13.75Sales Q/Q2.94%SMA50-0.52%Rel Volume1.13Prev Close20.34
Employees357LT Debt/Eq5.36EarningsOct 26SMA20014.36%Avg Volume123.49KPrice20.78
IPO DateMay 23, 2013Option/ShortYes / YesEPS/Sales Surpr.306.67% -Net Debt/EBITDA3.71Volume139,259Change2.16%
Latest News
Aug-03-26
Jul-29-26
Jul-28-26
Jul-24-26
Jul-23-26
Jun-22-26
Company

National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue140137143
Cost of Goods Sold Incl. D&A476057
Gross Profit937786
Selling, General and Administrative Excl. Other625545
Research and Development
000
Other Operating Expense1606
Operating Income162335
Interest Expense453
Unusual Expense
Non-Operating Income (Expense)
000
Net Income Before Taxes81833
Income Taxes368
Consolidated Net Income61225
Net Income From Continuing Operations61225
Net Income61225
EPS (Recurring)0.260.521.05
EPS (Basic, Before Extraordinaries)0.260.521.05
EPS (Diluted)0.250.521.04
EBITDA243041
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio83.1236.1016.96
Price To Sales Ratio3.273.012.96
Gross Margin66.4356.2060.14
Operating Margin11.4316.7924.48
Net Margin4.298.7617.48
Shares Outstanding222224
Market Capitalization457413423
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$24.47$20.78$17.09$13.41$9.72 Close Price0.00K24.54K49.08K73.62K98.16KUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
HARRISON SHANE REVP & Chief Financial OfficerFeb 17 '26Buy12.278,00098,1628,000Feb 19
Hays Michael D.ChairmanJan 05 '26Option Exercise15.239,145139,27820,154Jan 07
Hrdy HelenEVP & Chief Operating OfficerDec 15 '25Option Exercise15.2312,346188,030151,762Dec 17
Freeman Jordan NicoleChief Accounting OfficerJul 31 '25Buy12.9777110,000771Aug 04
BEANS PATRICK E10% OwnerMay 12 '25Buy13.592,50033,97435,003May 13
Hays Michael D.CEO & PresidentJan 02 '25Option Exercise13.1710,014131,88411,009Jan 06
NUNNELLY JOHN NDirectorMar 27 '24Option Exercise14.959,259138,42236,153Mar 29
Common Property Trust10% OwnerMar 01 '24Sale40.54598,65324,269,3933,854,284Mar 05
Amandla MK Trust10% OwnerJan 05 '24Sale40.202,614105,0923,831,362Jan 08
Amandla MK Trust10% OwnerJan 04 '24Sale41.224,600189,6173,833,976Jan 08
Common Property Trust10% OwnerJan 03 '24Sale41.53364,62515,142,8764,452,937Jan 05
Amandla MK Trust10% OwnerJan 03 '24Sale41.77120,1395,018,7593,838,576Jan 04
Hays Michael D.CEO & PresidentJan 02 '24Option Exercise18.802,90454,5952,904Jan 04
Amandla MK Trust10% OwnerJan 02 '24Sale40.31201,1008,106,2463,958,715Jan 04
Amandla MK Trust10% OwnerDec 14 '23Sale41.5960024,9544,159,815Dec 14
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.